PFKM and neoplasm: It has been discovered that Cyclin D3 can phosphorylate and deactivate PFK1 (phosphofructokinase 1) and PKM2 (pyruvate kinase m2), consequently inhibiting glycolysis during G1 phase while weakening energy supply to tumor cells (12, 13).